Last updated on December 2019

Effects of Oral Sildenafil on Mortality in Adults With PAH


Brief description of study

This is a blinded study in adult patients with PAH evaluating the relative effects of sildenafil on mortality when administered at the three doses (80 mg, 20 mg or 5 mg, all three times per day [TID]). In addition, the relative effects on clinical worsening and 6-minute walking distance (6MWD) will be assessed.

Clinical Study Identifier: NCT02060487

Find a site near you

Start Over

The Emory Clinic

Atlanta, GA United States
  Connect »

Spectrum Health Hospitals

Grand Rapids, MI United States
  Connect »

Spectrum Health

Grand Rapids, MI United States
  Connect »

Robert V. Sibilia MD, Inc.

Wooster, OH United States
  Connect »

St. Vincent's Hospital

Darlinghurst, Australia
  Connect »

Westmead Hospital

Westmead, Australia
  Connect »

BH Heart Center Tuzla

Tuzla, Bosnia and Herzegovina
  Connect »

Clinical Center University Sarajevo

Sarajevo, Bosnia and Herzegovina
  Connect »

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »

Prince of Wales Hospital

Shatin, New Territories, Hong Kong
  Connect »

Center of Chest Diseases

Johannesburg, South Africa
  Connect »

Dr PG Williams Practice

Johannesburg, South Africa
  Connect »